NCT04129723

Stopping Biological Therapy in PCD Study

Stopping Biological Therapy in Perianal Crohn's Disease Patients With Radiologically Healed Fistulas: a Prospective Cohort Study

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Chinese University of Hong Kong · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this which studied the biological therapy can be safely withdrawn in perianal Crohn's disease patients with radiologically healed fistula on MRI pelvis.

Detailed description

This clinical trial in perianal Crohn's disease patients with radiologically healed fistula on MRI pelvis which studied the biological therapy can be safely withdrawn. The primary endpoint is clinical relapse at 12 months.

Conditions

• Perianal Crohn Disease
• MRI
• Biological Therapy

Interventions

Type	Name	Description
OTHER	Stopping biological therapy	Stopping biological therapy The primary endpoint is clinical relapse at 12 months

Timeline

• Start date: 2022-01-01
• Primary completion: 2023-12-31
• Completion: 2025-12-31
• First posted: 2019-10-17
• Last updated: 2022-01-28

Locations

1 site across 1 country: Hong Kong